首页 > 最新文献

Annals of vascular diseases最新文献

英文 中文
Vascular Surgery in Japan: 2018 Annual Report by the Japanese Society for Vascular Surgery. 日本血管外科:日本血管外科学会2018年年度报告。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-09-18 DOI: 10.3400/avd.ar.24-00052

Objectives: This is an annual report indicating the number and early clinical results of annual vascular treatment performed by vascular surgeons in Japan in 2018, as analyzed by database management committee (DBC) members of the Japanese Society for Vascular Surgery (JSVS). Materials and Methods: To survey the current status of vascular treatments performed by vascular surgeons in Japan, the DBC members of the JSVS analyzed the vascular treatment data provided by the National Clinical Database (NCD), including the number of treatments and early results such as operative and hospital mortality. Results: In total, 143,745 vascular treatments were registered by 1,090 institutions in 2018. This database comprises seven fields, including treatment of aneurysms, chronic arterial occlusive disease, acute arterial occlusive disease, vascular injury, complication of previous vascular reconstruction, venous diseases, and other vascular treatments. The number of vascular treatments in each field was 24,495, 18,700, 4,813, 2,363, 694, 45,088, and 47,592, respectively. In the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA), including common iliac aneurysm, were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA. The operative mortality rates of ruptured and unruptured AAA were 15.7% and 0.6%, respectively. Approximately 43.3% of ruptured AAA were treated by EVAR, and the EVAR ratio was gradually increasing, but the operative mortality rates of open repair and EVAR for ruptured AAA were 14.0% and 14.6%, respectively. Regarding chronic arterial occlusive disease, open repair was performed in 8,336 cases, including 1,348 distal bypasses to the crural or pedal artery, whereas endovascular treatment (EVT) was performed in 9,710 cases. The EVT ratio was gradually increased at 51.9%. Varicose vein treatment was decreased in 43,133 cases (7.7% less than that in 2017), and 77.3% of the cases were treated by endovenous thermal ablation (ETA), including endovenous laser ablation (EVLA) and radiofrequency ablation (RFA). Regarding other vascular operations, 44,003 cases of vascular access operations and 1,631 lower limb amputation surgeries were included. Conclusions: The number of vascular treatments increased since 2017, and the proportion of endovascular procedures increased in almost all fields of vascular diseases, especially EVAR for AAA, EVT for chronic arterial occlusive disease, and ETA for varicose veins. (This is a translation of Jpn J Vasc Surg 2022; 31: 217-237.).

目的:这是一份年度报告,根据日本血管外科学会(JSVS)的数据库管理委员会(DBC)成员的分析,显示了2018年日本血管外科医生进行的年度血管治疗的数量和早期临床结果。材料与方法:为了调查日本血管外科医生进行血管治疗的现状,JSVS的DBC成员分析了国家临床数据库(National Clinical Database, NCD)提供的血管治疗数据,包括治疗次数以及手术和住院死亡率等早期结果。结果:2018年,1090家机构共登记血管治疗143745例。该数据库包括7个领域,包括动脉瘤的治疗、慢性动脉闭塞疾病、急性动脉闭塞疾病、血管损伤、既往血管重建并发症、静脉疾病和其他血管治疗。各领域血管处理件数分别为24,495件、18,700件、4,813件、2,363件、694件、45,088件和47,592件。在动脉瘤治疗领域,共登记腹主动脉瘤(AAA) 20160例,其中包括常见的髂动脉瘤,61.6%的患者接受了血管内动脉瘤修复术(EVAR)。其中AAA破裂1794例(8.9%),手术死亡率分别为15.7%和0.6%。约43.3%的AAA破裂行EVAR治疗,且EVAR比例逐渐上升,但AAA破裂开腹修复和EVAR的手术死亡率分别为14.0%和14.6%。对于慢性动脉闭塞性疾病,8,336例进行了开放修复,包括1,348例远端脚动脉或脚动脉旁路,而9,710例进行了血管内治疗(EVT)。EVT比率逐渐上升至51.9%。静脉曲张治疗减少43133例(比2017年减少7.7%),77.3%的病例采用静脉内热消融(ETA)治疗,包括静脉内激光消融(EVLA)和射频消融(RFA)。其他血管手术44003例,下肢截肢手术1631例。结论:自2017年以来,血管治疗数量有所增加,几乎所有血管疾病领域的血管内手术比例均有所增加,尤其是AAA的EVAR、慢性动脉闭塞性疾病的EVT和静脉曲张的ETA。(这是Jpn J Vasc Surg 2022的翻译;31日:217 - 237)。
{"title":"Vascular Surgery in Japan: 2018 Annual Report by the Japanese Society for Vascular Surgery.","authors":"","doi":"10.3400/avd.ar.24-00052","DOIUrl":"10.3400/avd.ar.24-00052","url":null,"abstract":"<p><p><b>Objectives:</b> This is an annual report indicating the number and early clinical results of annual vascular treatment performed by vascular surgeons in Japan in 2018, as analyzed by database management committee (DBC) members of the Japanese Society for Vascular Surgery (JSVS). <b>Materials and Methods:</b> To survey the current status of vascular treatments performed by vascular surgeons in Japan, the DBC members of the JSVS analyzed the vascular treatment data provided by the National Clinical Database (NCD), including the number of treatments and early results such as operative and hospital mortality. <b>Results:</b> In total, 143,745 vascular treatments were registered by 1,090 institutions in 2018. This database comprises seven fields, including treatment of aneurysms, chronic arterial occlusive disease, acute arterial occlusive disease, vascular injury, complication of previous vascular reconstruction, venous diseases, and other vascular treatments. The number of vascular treatments in each field was 24,495, 18,700, 4,813, 2,363, 694, 45,088, and 47,592, respectively. In the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA), including common iliac aneurysm, were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA. The operative mortality rates of ruptured and unruptured AAA were 15.7% and 0.6%, respectively. Approximately 43.3% of ruptured AAA were treated by EVAR, and the EVAR ratio was gradually increasing, but the operative mortality rates of open repair and EVAR for ruptured AAA were 14.0% and 14.6%, respectively. Regarding chronic arterial occlusive disease, open repair was performed in 8,336 cases, including 1,348 distal bypasses to the crural or pedal artery, whereas endovascular treatment (EVT) was performed in 9,710 cases. The EVT ratio was gradually increased at 51.9%. Varicose vein treatment was decreased in 43,133 cases (7.7% less than that in 2017), and 77.3% of the cases were treated by endovenous thermal ablation (ETA), including endovenous laser ablation (EVLA) and radiofrequency ablation (RFA). Regarding other vascular operations, 44,003 cases of vascular access operations and 1,631 lower limb amputation surgeries were included. <b>Conclusions:</b> The number of vascular treatments increased since 2017, and the proportion of endovascular procedures increased in almost all fields of vascular diseases, especially EVAR for AAA, EVT for chronic arterial occlusive disease, and ETA for varicose veins. (This is a translation of Jpn J Vasc Surg 2022; 31: 217-237.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"467-487"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left Common Iliac Artery Aneurysm Rupture to an Iliac Vein with a Venous Anomaly: A Case Report. 左髂总动脉瘤破裂至髂静脉并静脉异常1例报告。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-10-24 DOI: 10.3400/avd.cr.24-00027
Shunta Hayakawa, Jien Saito, Shinji Kamiya, Yoshiaki Sone, Yukihide Numata, Hideki Sasaki

Ruptured iliac artery aneurysms are serious conditions with high mortality, occasionally perforating into the venous system. A 73-year-old male presented with left leg edema and a pulsatile left lower abdominal mass. Computed tomography revealed a ruptured left common iliac artery aneurysm with perforation into the left common iliac vein. Additionally, bilateral internal iliac veins were noted to form an anomalous common trunk draining into the left common iliac vein. Treatment involved internal iliac vein balloon occlusion under fluoroscopy followed by open surgery for artificial graft replacement and fistula repair. The patient was discharged on the 8th postoperative day.

髂动脉动脉瘤破裂是一种严重的疾病,死亡率很高,偶尔会穿孔进入静脉系统。73岁男性,左腿水肿,左下腹部搏动性肿块。计算机断层扫描显示左侧髂总动脉瘤破裂并穿孔至左侧髂总静脉。此外,双侧髂内静脉形成异常总干,流入左侧髂总静脉。治疗包括透视下髂内静脉球囊闭塞,随后开放手术进行人工移植物置换和瘘管修复。患者于术后第8天出院。
{"title":"Left Common Iliac Artery Aneurysm Rupture to an Iliac Vein with a Venous Anomaly: A Case Report.","authors":"Shunta Hayakawa, Jien Saito, Shinji Kamiya, Yoshiaki Sone, Yukihide Numata, Hideki Sasaki","doi":"10.3400/avd.cr.24-00027","DOIUrl":"10.3400/avd.cr.24-00027","url":null,"abstract":"<p><p>Ruptured iliac artery aneurysms are serious conditions with high mortality, occasionally perforating into the venous system. A 73-year-old male presented with left leg edema and a pulsatile left lower abdominal mass. Computed tomography revealed a ruptured left common iliac artery aneurysm with perforation into the left common iliac vein. Additionally, bilateral internal iliac veins were noted to form an anomalous common trunk draining into the left common iliac vein. Treatment involved internal iliac vein balloon occlusion under fluoroscopy followed by open surgery for artificial graft replacement and fistula repair. The patient was discharged on the 8th postoperative day.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"413-416"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative Evaluation of Peripheral Nerve Injury in Endovenous Laser Ablation with or without Microphlebectomy: Prospective Cohort Study of 25 Cases. 25例静脉内激光消融伴或不伴小静脉切除术对周围神经损伤的定量评价。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-10-15 DOI: 10.3400/avd.oa.24-00031
Atsushi Hiromoto, Shun-Ichiro Sakamoto, Kenji Suzuki, Yosuke Ishii

Objectives: This study aimed to quantitatively evaluate peripheral nerve injury (PNI) after varicose vein (VV) surgery using endovenous laser ablation (EVLA). Methods: Overall, 25 cases were analyzed. All patients underwent EVLA of the great saphenous vein (GSV) with or without resection of the varix of the GSV tributaries in stab and avulsion fashion (microphlebectomy). For evaluation of PNI, the current perception threshold (CPT) was measured preoperatively at 1 week, 1 month, 3 months, and 6 months postoperatively. In each leg, CPT was measured at 6 points. PNI was defined as >40% elevation from preoperative data. Results: A significant elevation in CPT was observed at 2 points (knee joint level [P = 0.01] and upper portion of the lower leg [P = 0.008]) 1 week postoperatively. CPT decreased after 1 month and recovered to the same level after 6 months. PNI occurred in 52% and 36% of patients at the knee joint level and upper portion of the lower leg, respectively. Microphlebectomy was indicated as a factor associated with PNI (P <0.01). Conclusions: Although VV surgery using EVLA is less invasive, the occurrence of transient PNI in the early postoperative period should be noted when concomitant microphlebectomy is performed.

目的:本研究旨在定量评价静脉内激光消融(EVLA)治疗静脉曲张(VV)术后周围神经损伤(PNI)。方法:对25例病例进行分析。所有患者均行大隐静脉(GSV) EVLA,同时或不以刺伤和撕脱方式切除GSV分支曲张(微静脉切除术)。为了评估PNI,在术前1周、1个月、3个月和6个月测量当前感知阈值(CPT)。在每条腿的6个点测量CPT。PNI定义为术前数据升高bb0 ~ 40%。结果:术后1周有2个点(膝关节水平[P = 0.01]和小腿上部[P = 0.008]) CPT明显升高。1个月后CPT下降,6个月后恢复到相同水平。PNI分别发生在52%和36%的患者膝关节水平和小腿上部。结论:虽然采用EVLA的VV手术创伤性较小,但在同时进行小静脉切除术时,应注意术后早期发生短暂性PNI的情况。
{"title":"Quantitative Evaluation of Peripheral Nerve Injury in Endovenous Laser Ablation with or without Microphlebectomy: Prospective Cohort Study of 25 Cases.","authors":"Atsushi Hiromoto, Shun-Ichiro Sakamoto, Kenji Suzuki, Yosuke Ishii","doi":"10.3400/avd.oa.24-00031","DOIUrl":"10.3400/avd.oa.24-00031","url":null,"abstract":"<p><p><b>Objectives:</b> This study aimed to quantitatively evaluate peripheral nerve injury (PNI) after varicose vein (VV) surgery using endovenous laser ablation (EVLA). <b>Methods:</b> Overall, 25 cases were analyzed. All patients underwent EVLA of the great saphenous vein (GSV) with or without resection of the varix of the GSV tributaries in stab and avulsion fashion (microphlebectomy). For evaluation of PNI, the current perception threshold (CPT) was measured preoperatively at 1 week, 1 month, 3 months, and 6 months postoperatively. In each leg, CPT was measured at 6 points. PNI was defined as >40% elevation from preoperative data. <b>Results:</b> A significant elevation in CPT was observed at 2 points (knee joint level [P = 0.01] and upper portion of the lower leg [P = 0.008]) 1 week postoperatively. CPT decreased after 1 month and recovered to the same level after 6 months. PNI occurred in 52% and 36% of patients at the knee joint level and upper portion of the lower leg, respectively. Microphlebectomy was indicated as a factor associated with PNI (P <0.01). <b>Conclusions:</b> Although VV surgery using EVLA is less invasive, the occurrence of transient PNI in the early postoperative period should be noted when concomitant microphlebectomy is performed.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"383-388"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Cases of Refractory Diarrhea Subsequent to Vascular Reconstruction for Infective Superior Mesenteric Artery Aneurysms. 感染性肠系膜上动脉瘤血管重建术后难治性腹泻2例。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-09-30 DOI: 10.3400/avd.cr.24-00080
Taiki Niki, Naoto Fukunaga, Tatsuto Wakami, Akio Shimoji, Kosuke Yoshizawa, Nobushige Tamura

Superior mesenteric artery (SMA) aneurysm and their surgical interventions are rare, leading to infrequent reports of postoperative complications. This report describes 2 cases of refractory diarrhea following vascular reconstruction for infectious SMA aneurysms. Both patients underwent aneurysm resection and SMA reconstruction but experienced persistent diarrhea despite treatment with anti-diarrheal medications. Postoperative diarrhea, a complication observed after resection of the nerve plexus around the SMA in gastrointestinal surgery, may be attributed to intraoperative injury to the nerve plexus in our cases. Though palliative therapy is partially effective, more efficacious management strategies are desirable to address this persistent complication.

肠系膜上动脉(SMA)动脉瘤及其手术干预是罕见的,导致术后并发症的报道很少。本文报告2例感染性SMA动脉瘤血管重建后的难治性腹泻。两名患者均接受了动脉瘤切除术和SMA重建,但尽管接受了抗腹泻药物治疗,但仍持续腹泻。术后腹泻是胃肠道手术切除SMA周围神经丛后的并发症,我们的病例可能归因于术中神经丛损伤。虽然姑息治疗是部分有效的,更有效的管理策略是可取的,以解决这种持续的并发症。
{"title":"Two Cases of Refractory Diarrhea Subsequent to Vascular Reconstruction for Infective Superior Mesenteric Artery Aneurysms.","authors":"Taiki Niki, Naoto Fukunaga, Tatsuto Wakami, Akio Shimoji, Kosuke Yoshizawa, Nobushige Tamura","doi":"10.3400/avd.cr.24-00080","DOIUrl":"10.3400/avd.cr.24-00080","url":null,"abstract":"<p><p>Superior mesenteric artery (SMA) aneurysm and their surgical interventions are rare, leading to infrequent reports of postoperative complications. This report describes 2 cases of refractory diarrhea following vascular reconstruction for infectious SMA aneurysms. Both patients underwent aneurysm resection and SMA reconstruction but experienced persistent diarrhea despite treatment with anti-diarrheal medications. Postoperative diarrhea, a complication observed after resection of the nerve plexus around the SMA in gastrointestinal surgery, may be attributed to intraoperative injury to the nerve plexus in our cases. Though palliative therapy is partially effective, more efficacious management strategies are desirable to address this persistent complication.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"426-428"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preceding Antiphospholipid Syndrome before the Onset of Systemic Lupus Erythematosus Presenting with Iliocaval Deep Vein Thrombosis: A Case Report and Literature Review. 以髂腔深静脉血栓形成为表现的系统性红斑狼疮发病前的抗磷脂综合征1例报告及文献复习。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-10-08 DOI: 10.3400/avd.cr.24-00040
Masaya Nakashima, Masayoshi Kobayashi

Antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) are similar to be characterized by thromboembolic events and various clinical manifestations. We experienced a 21-year-old man with acute iliocaval deep vein thrombosis (DVT). Primary APS was initially diagnosed on the criteria, and after multidisciplinary treatment, iliocaval DVT was gradually regressed. Six months later, the patient complained of acute enteritis, followed by peripheral neuropathy and butterfly lupus. SLE was diagnosed, which suggested that the onset of SLE was preceded by APS. This case raises the question of a present consensus that these two diseases are clearly different clinical entities, although these are closely related.

抗磷脂综合征(APS)和系统性红斑狼疮(SLE)相似,其特征是血栓栓塞事件和多种临床表现。我们经历了一个21岁的男性急性髂腔深静脉血栓形成(DVT)。原发性APS初步诊断符合标准,经多学科治疗,髂腔DVT逐渐消退。6个月后,患者主诉急性肠炎,接着是周围神经病变和蝴蝶狼疮。诊断为SLE,提示SLE发病前有APS。这个病例提出了一个问题,目前的共识,这两种疾病是明显不同的临床实体,尽管它们是密切相关的。
{"title":"Preceding Antiphospholipid Syndrome before the Onset of Systemic Lupus Erythematosus Presenting with Iliocaval Deep Vein Thrombosis: A Case Report and Literature Review.","authors":"Masaya Nakashima, Masayoshi Kobayashi","doi":"10.3400/avd.cr.24-00040","DOIUrl":"10.3400/avd.cr.24-00040","url":null,"abstract":"<p><p>Antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) are similar to be characterized by thromboembolic events and various clinical manifestations. We experienced a 21-year-old man with acute iliocaval deep vein thrombosis (DVT). Primary APS was initially diagnosed on the criteria, and after multidisciplinary treatment, iliocaval DVT was gradually regressed. Six months later, the patient complained of acute enteritis, followed by peripheral neuropathy and butterfly lupus. SLE was diagnosed, which suggested that the onset of SLE was preceded by APS. This case raises the question of a present consensus that these two diseases are clearly different clinical entities, although these are closely related.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"409-412"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical Pitfalls and Tips of Management for Critical Limb Ischemia by Distal Bypass Using the Autogenous Veins. 自体静脉远端搭桥治疗危重肢体缺血的技术陷阱和处理技巧。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-09-04 DOI: 10.3400/avd.ra.24-00066
Taku Kokubo, Shinya Okata, Kayoko Natsume, Tadahiro Sasajima

It is a clear fact that many complications in surgical treatment, not just in cardiovascular surgery, are caused by things related to surgical techniques. In other words, postoperative problems are already determined by preoperative surgical management and intraoperative surgical operations. This describes strategies to avoid the surgical complications of distal bypass using the autogenous veins for each item. (This is a translation of Jpn J Vasc Surg 2024; 33: 67-72).

很明显,手术治疗中的许多并发症,不仅仅是心血管手术,都是由与手术技术有关的事情引起的。换句话说,术后问题已经由术前手术管理和术中手术决定。本文描述了在每个项目中使用自体静脉来避免远端搭桥手术并发症的策略。(这是Jpn J Vasc surgery 2024的翻译;33: 67 - 72)。
{"title":"Technical Pitfalls and Tips of Management for Critical Limb Ischemia by Distal Bypass Using the Autogenous Veins.","authors":"Taku Kokubo, Shinya Okata, Kayoko Natsume, Tadahiro Sasajima","doi":"10.3400/avd.ra.24-00066","DOIUrl":"10.3400/avd.ra.24-00066","url":null,"abstract":"<p><p>It is a clear fact that many complications in surgical treatment, not just in cardiovascular surgery, are caused by things related to surgical techniques. In other words, postoperative problems are already determined by preoperative surgical management and intraoperative surgical operations. This describes strategies to avoid the surgical complications of distal bypass using the autogenous veins for each item. (This is a translation of Jpn J Vasc Surg 2024; 33: 67-72).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"345-350"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly Expanding Fusiform Abdominal Aortic Aneurysm without Stenotic Lesion Caused by Fibromuscular Dysplasia: A Rare Case. 纤维肌肉发育不良引起的快速扩张梭状腹主动脉瘤无狭窄病变一例。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-11-27 DOI: 10.3400/avd.cr.24-00110
Shinya Masuda, Daichi Takahashi, Kazuaki Yanagiya, Masayuki Otani, Ko Sakatsume, Nobuaki Suzuki, Ichiro Yoshioka, Masaharu Hatakeyama, Hidekachi Kurotaki, Koichi Nagaya

Fibromuscular dysplasia (FMD) is an arterial disease characterized by fibrous arterial wall thickening and irregular proliferation and degeneration of smooth muscle cells in muscular arteries. Abdominal aortic aneurysms (AAA) are rare, with only a few reported cases. A characteristic feature of AAA is an aneurysm protruding forward near the terminal aorta with stenosis. Here, we report a rare case of a 66-year-old woman who underwent abdominal aortic replacement for a fusiform AAA, diagnosed with aortic FMD (without stenotic lesions) on pathological examination.

纤维肌肉发育不良(FMD)是一种以纤维动脉壁增厚和肌肉动脉平滑肌细胞不规则增生和变性为特征的动脉疾病。腹主动脉瘤(AAA)是罕见的,只有少数报告的病例。AAA的一个特征性特征是动脉瘤向前突出靠近末段主动脉并狭窄。在此,我们报告一个罕见的66岁女性病例,她接受了腹主动脉置换术治疗梭状AAA,在病理检查中诊断为主动脉FMD(无狭窄病变)。
{"title":"Rapidly Expanding Fusiform Abdominal Aortic Aneurysm without Stenotic Lesion Caused by Fibromuscular Dysplasia: A Rare Case.","authors":"Shinya Masuda, Daichi Takahashi, Kazuaki Yanagiya, Masayuki Otani, Ko Sakatsume, Nobuaki Suzuki, Ichiro Yoshioka, Masaharu Hatakeyama, Hidekachi Kurotaki, Koichi Nagaya","doi":"10.3400/avd.cr.24-00110","DOIUrl":"10.3400/avd.cr.24-00110","url":null,"abstract":"<p><p>Fibromuscular dysplasia (FMD) is an arterial disease characterized by fibrous arterial wall thickening and irregular proliferation and degeneration of smooth muscle cells in muscular arteries. Abdominal aortic aneurysms (AAA) are rare, with only a few reported cases. A characteristic feature of AAA is an aneurysm protruding forward near the terminal aorta with stenosis. Here, we report a rare case of a 66-year-old woman who underwent abdominal aortic replacement for a fusiform AAA, diagnosed with aortic FMD (without stenotic lesions) on pathological examination.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"443-446"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Direct Oral Anticoagulation for Isolated Distal Deep Vein Thrombosis in Japanese Orthopedic Patients. 直接口服抗凝治疗日本骨科患者远端深静脉血栓形成。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-09-23 DOI: 10.3400/avd.oa.24-00061
Ayumi Omura, Hiroyoshi Mori, Masahiro Sasai, Takahiro Tezuka, Daisuke Wada, Hiromoto Sone, Yosuke Takei, Kazuma Tashiro, Tokutada Sato, Mio Ebato, Hiroshi Suzuki

Objectives: Although direct oral anticoagulants (DOAC) have become widely used, little is known about the efficacy of DOAC for isolated distal deep vein thrombosis (DVT). Methods: In-hospitalized orthopedic patients with isolated distal DVT who were diagnosed from 2016 to 2018 were enrolled and were followed for 1 year. Embolic events included symptomatic pulmonary embolism (PE) and DVT extension above the knee. Bleeding events were determined in the presence of bleeding academic research consortium (BARC) 2, 3 or 5 bleeding. Results: Of 196 orthopedic patients, 84% of patients (n = 164) received DOAC (DOAC+ group), whereas 16% of patients (n = 32) did not (DOAC- group). Cumulative incidence of embolic events was observed in 1.5% of the DOAC+ group and none of the DOAC- group (p = 0.443). Cumulative incidence of bleeding events was observed in 5.1% of the DOAC+ group and none of the DOAC- group (p = 0.157). The majority of bleeding events (80%) occurred in patients with HAS-BLED scores of 3 or greater. Conclusions: There were no significant differences in embolic events and bleeding events in retrospective data. Balancing thrombotic risk and bleeding risk remains to be key for isolated distal DVT.

目的:虽然直接口服抗凝剂(DOAC)已被广泛使用,但DOAC对孤立性远端深静脉血栓形成(DVT)的疗效知之甚少。方法:选取2016 - 2018年住院的骨科孤立性远端DVT患者,随访1年。栓塞事件包括症状性肺栓塞(PE)和深静脉血栓延伸至膝盖以上。在出现出血的学术研究联盟(BARC) 2、3或5出血的情况下确定出血事件。结果:196例骨科患者中,84% (n = 164)患者接受了DOAC治疗(DOAC+组),16% (n = 32)患者未接受DOAC治疗(DOAC-组)。DOAC+组的累积栓塞事件发生率为1.5%,DOAC-组为零(p = 0.443)。DOAC+组的累积出血事件发生率为5.1%,DOAC-组为零(p = 0.157)。大多数出血事件(80%)发生在ha - bled评分为3分或更高的患者中。结论:在回顾性数据中,栓塞事件和出血事件无显著差异。平衡血栓形成风险和出血风险仍然是孤立远端深静脉血栓形成的关键。
{"title":"Use of Direct Oral Anticoagulation for Isolated Distal Deep Vein Thrombosis in Japanese Orthopedic Patients.","authors":"Ayumi Omura, Hiroyoshi Mori, Masahiro Sasai, Takahiro Tezuka, Daisuke Wada, Hiromoto Sone, Yosuke Takei, Kazuma Tashiro, Tokutada Sato, Mio Ebato, Hiroshi Suzuki","doi":"10.3400/avd.oa.24-00061","DOIUrl":"10.3400/avd.oa.24-00061","url":null,"abstract":"<p><p><b>Objectives:</b> Although direct oral anticoagulants (DOAC) have become widely used, little is known about the efficacy of DOAC for isolated distal deep vein thrombosis (DVT). <b>Methods:</b> In-hospitalized orthopedic patients with isolated distal DVT who were diagnosed from 2016 to 2018 were enrolled and were followed for 1 year. Embolic events included symptomatic pulmonary embolism (PE) and DVT extension above the knee. Bleeding events were determined in the presence of bleeding academic research consortium (BARC) 2, 3 or 5 bleeding. <b>Results:</b> Of 196 orthopedic patients, 84% of patients (n = 164) received DOAC (DOAC+ group), whereas 16% of patients (n = 32) did not (DOAC- group). Cumulative incidence of embolic events was observed in 1.5% of the DOAC+ group and none of the DOAC- group (p = 0.443). Cumulative incidence of bleeding events was observed in 5.1% of the DOAC+ group and none of the DOAC- group (p = 0.157). The majority of bleeding events (80%) occurred in patients with HAS-BLED scores of 3 or greater. <b>Conclusions:</b> There were no significant differences in embolic events and bleeding events in retrospective data. Balancing thrombotic risk and bleeding risk remains to be key for isolated distal DVT.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"371-377"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy after Endovascular Therapy in Patients with Lower Extremity Artery Disease. 下肢动脉病患者血管内治疗后单次抗血小板治疗与双次抗血小板治疗的比较。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-11-29 DOI: 10.3400/avd.oa.24-00056
Takehiro Yamada, Takahiro Tokuda, Naoki Yoshioka, Akio Koyama, Ryusuke Nishikawa, Kiyotaka Shimamura, Takuma Aoyama

Objectives: Evidence for antithrombotic therapy after endovascular therapy (EVT) is limited. Methods: This retrospective, multicenter, observational study enrolled 732 consecutive patients with lower extremity artery disease who underwent EVT between January 2018 and December 2019. Overall, 570 patients who received single antiplatelet therapy (SAPT) and dual antiplatelet therapy (DAPT) were selected and divided into the SAPT (n = 189) and DAPT (n = 381) groups. The primary outcome was bleeding events at 24 months. The secondary outcomes were bleeding events at 30 days and 24 months after 30 days, ischemic events, and all-cause death at 24 months. Bleeding and ischemic events at 24 months were investigated in subgroups. Results: A propensity score matching yielded 164 patients in both groups. There were no significant differences in bleeding events between the SAPT and DAPT groups (14.2% and 11.3% at 24 months, p = 0.775; 2.5% and 6.1% at 30 days, p = 0.106; 11.7% and 6.7% at 24 months after 30 days, p = 0.162). Additionally, there was no significant difference in ischemic events at 24 months between the two groups (32.7% and 30.6%, p = 0.625). Bleeding and ischemic events at 24 months were similar between subgroups. Conclusions: No significant differences in bleeding or ischemic events between SAPT and DAPT were observed.

目的:血管内治疗(EVT)后抗血栓治疗的证据有限。方法:这项回顾性、多中心、观察性研究纳入了732例连续的下肢动脉疾病患者,这些患者在2018年1月至2019年12月期间接受了EVT。总的来说,选择570例接受单一抗血小板治疗(SAPT)和双重抗血小板治疗(DAPT)的患者,分为SAPT组(n = 189)和DAPT组(n = 381)。主要结局是24个月时的出血事件。次要结局是30天和30天后24个月的出血事件、缺血事件和24个月的全因死亡。在24个月时按亚组调查出血和缺血事件。结果:倾向评分匹配两组共164例患者。SAPT组和DAPT组之间出血事件无显著差异(24个月时14.2%和11.3%,p = 0.775;30天2.5%和6.1%,p = 0.106;30天后24个月11.7%和6.7%,p = 0.162)。此外,两组24个月缺血事件发生率无显著差异(32.7%和30.6%,p = 0.625)。24个月时,各亚组间出血和缺血事件相似。结论:SAPT和DAPT在出血或缺血事件方面无显著差异。
{"title":"Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy after Endovascular Therapy in Patients with Lower Extremity Artery Disease.","authors":"Takehiro Yamada, Takahiro Tokuda, Naoki Yoshioka, Akio Koyama, Ryusuke Nishikawa, Kiyotaka Shimamura, Takuma Aoyama","doi":"10.3400/avd.oa.24-00056","DOIUrl":"10.3400/avd.oa.24-00056","url":null,"abstract":"<p><p><b>Objectives:</b> Evidence for antithrombotic therapy after endovascular therapy (EVT) is limited. <b>Methods:</b> This retrospective, multicenter, observational study enrolled 732 consecutive patients with lower extremity artery disease who underwent EVT between January 2018 and December 2019. Overall, 570 patients who received single antiplatelet therapy (SAPT) and dual antiplatelet therapy (DAPT) were selected and divided into the SAPT (n = 189) and DAPT (n = 381) groups. The primary outcome was bleeding events at 24 months. The secondary outcomes were bleeding events at 30 days and 24 months after 30 days, ischemic events, and all-cause death at 24 months. Bleeding and ischemic events at 24 months were investigated in subgroups. <b>Results:</b> A propensity score matching yielded 164 patients in both groups. There were no significant differences in bleeding events between the SAPT and DAPT groups (14.2% and 11.3% at 24 months, p = 0.775; 2.5% and 6.1% at 30 days, p = 0.106; 11.7% and 6.7% at 24 months after 30 days, p = 0.162). Additionally, there was no significant difference in ischemic events at 24 months between the two groups (32.7% and 30.6%, p = 0.625). Bleeding and ischemic events at 24 months were similar between subgroups. <b>Conclusions:</b> No significant differences in bleeding or ischemic events between SAPT and DAPT were observed.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"396-404"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pinhole Descending Aortic Rupture with Systemic Sclerosis and Dermatomyositis: A Case Report. 针孔降主动脉破裂合并系统性硬化症及皮肌炎1例。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-25 Epub Date: 2024-10-29 DOI: 10.3400/avd.cr.24-00108
Norihiro Ando, Ryuichi Nabeshima, Taiki Ito, Koji Sato, Hiroshi Sugiki

Thoracic descending aortic perforation with overlap syndrome (systemic sclerosis and dermatomyositis) is a rare, unreported vascular pathology. We describe the case of a 75-year-old woman who presented with chest tightness, back pain, and dyspnea. Computed tomography revealed a pinhole rupture in the descending aorta. The patient underwent a thoracic endovascular aortic repair and left chest drainage. Her postoperative course was uneventful.

胸降主动脉穿孔合并重叠综合征(系统性硬化症和皮肌炎)是一种罕见的、未报道的血管病理。我们描述了一个75岁的妇女谁提出胸闷,背部疼痛,呼吸困难的情况。计算机断层扫描显示降主动脉有针孔破裂。患者接受了胸腔血管内主动脉修复术和左胸引流术。她的术后过程很顺利。
{"title":"Pinhole Descending Aortic Rupture with Systemic Sclerosis and Dermatomyositis: A Case Report.","authors":"Norihiro Ando, Ryuichi Nabeshima, Taiki Ito, Koji Sato, Hiroshi Sugiki","doi":"10.3400/avd.cr.24-00108","DOIUrl":"10.3400/avd.cr.24-00108","url":null,"abstract":"<p><p>Thoracic descending aortic perforation with overlap syndrome (systemic sclerosis and dermatomyositis) is a rare, unreported vascular pathology. We describe the case of a 75-year-old woman who presented with chest tightness, back pain, and dyspnea. Computed tomography revealed a pinhole rupture in the descending aorta. The patient underwent a thoracic endovascular aortic repair and left chest drainage. Her postoperative course was uneventful.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 4","pages":"437-439"},"PeriodicalIF":0.6,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of vascular diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1